Q/C Technologies Inc. Common Stock (QCLS)

FairStock Score: 28/100 — RISKY

Key Financials

AI Analysis

AI-generated, general educational analysis — not personal investment advice.

I am wary when a company has no revenue and a handful of employees, even if the price looks low. Q/C Technologies, at a $4.5 million market cap and $0.55 close on 2026-10-13, is a clinical-stage pharmaceutical and computing-technology story. The filed results show no revenue in any of the periods given, and the losses tell the real story: net loss was $23.4 million in FY2024, $11.6 million in FY2025, $1.2 million in fiscal Q1 2026 (quarter ended 2026-03-31), and $6.6 million in fiscal Q2 2026 (quarter ended 2026-06-30). That is not a business with a moat I can identify; it is a collection of pipeline hopes with no reported sales. Financial health is poor. FairStock's trailing free cash flow is -$11.6 million, a -259.4% FCF yield against market cap. Piotroski is 1/9, Altman Z is -8.49, ROE is -108%, and ROCE is -33.44%. The only balance-sheet comfort is low leverage, with D/E of 0.02. Valuation is odd: P/B is 0.28, so the stock trades below accounting book value, and P/E is negative. Graham might call that a statistical bargain only if assets are real and earnings power exists; here there is no earnings power. Buffett would ask for durable competitive advantage and consistent cash generation. I see neither. Growth is not meaningful without revenue. A 2.11 beta and a 52-week range of $0.42 to $8.17 show how volatile the story is. The low price may reflect distress, not opportunity. I would need evidence of revenue, narrowing cash burn, and clinical or commercial validation before calling this anything but speculative.

In plain English: Q/C Technologies is a very small company trying to develop experimental drugs and also has a computing technology segment. The filed reports show no sales, and it has lost money in each recent year. The stock looks cheap compared with its accounting value, but the business itself looks weak and unproven.

The full AI analysis, bull and bear case and key monitorables are in FairStock Pro.

Data as of 2026-10-13 close · note generated 2026-10-15 · model deepseek-flash

Sources (SEC EDGAR): fiscal Q2 2026 10-Q (period ended 2026-06-30) · fiscal Q1 2026 10-Q (period ended 2026-03-31) · fiscal Q3 2025 10-Q (period ended 2025-09-30) · fiscal Q2 2025 10-Q (period ended 2025-06-30) · FY2025 10-K (period ended 2025-12-31) · FY2024 10-K (period ended 2024-12-31) · FY2023 10-K (period ended 2023-12-31)

Fundamentals from company filings and market-data providers; prices are end-of-day, not real-time. AI-generated analysis is general and educational — not personal investment advice. Scoring methodology · Score test · Disclaimer